Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 9, 2025Circulation Research

Abstract Thu156: Impacts of Estradiol and Progesterone On Cardiomyocyte Cell Dynamics and Mitochondrial Respiration

View Full Paper
Ask AI
Bookmark
Share

Authors

GHGlen R. HansonCHChristopher HofferPRPrema Ramaswamy

Discussion

Loading...

Member takes

Overview

Experimental analysis reveals that estradiol and progesterone significantly enhance cardiomyocyte function, indicating the role of female sex hormones in cardiac health.

Key Points

  • Treatment with estradiol and progesterone significantly improves cardiomyocyte function and mitochondrial respiration.
  • Cells treated with 100nM estradiol showed increased return velocity and percent shortening compared to vehicle controls.
  • Mitochondrial respiration was significantly enhanced in cardiomyocytes treated with estradiol and the combination therapy.
  • Findings emphasize the protective role of female sex hormones against cardiac dysfunction after menopause.

Cite This Study

Hanson et al. (2025) studied this question.

synapsesocial.com/papers/68e80eb363e2e2f707877dechttps://doi.org/10.1161/res.137.suppl_1.thu156
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Contractile Function of Ventricular Cardiomyocytes Is More Sensitive to Acute 17β-Estradiol Treatment Compared to Atrial Cardiomyocytes2025 · 2 citations
  2. 2Oestrogen changed cardiomyocyte contraction and β‐adrenoceptor expression in rat hearts subjected to ischaemia–reperfusion2008 · 60 citations
  3. 3Effects of estrogen on composition and function of cardiac muscle1959 · 25 citations
  4. 4Sex-specific modification of progesterone receptor expression by 17β-oestradiol in human cardiac tissues2010 · 41 citations
  5. 5Progesterone preserves eNOS coupling and supports endothelium-dependent vasodilation in the pulmonary artery of female rats: a potential therapeutic strategy for pulmonary arterial hypertension2025